1-hexadecanoyl-2-[(7Z,10Z,13Z,16Z)-docosatetraenoyl]-sn-glycero-3-phosphocholine

Metabolite details

Identifier

IRWRFKUTKSUFST-MDYGELLQSA-N

InChI Key

IRWRFKUTKSUFST-MDYGELLQSA-N

IUPAC name

(2R)-2-{[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxy}-3-(hexadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1-hexadecanoyl-2-[(7Z,10Z,13Z,16Z)-docosatetraenoyl]-sn-glycero-3-phosphocholine

INN name

—

Synonym

Phosphatidylcholine(16:0/22:4n6)

ChEBI

CHEBI:84573

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multiomics of synaptic junctions reveals altered lipid metabolism and signaling following environmental enrichment
• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Fatty acid oxidation protects cancer cells from apoptosis through increasing mitochondrial membrane lipids
• Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity

Observed in differential profiles

• Mus_musculus_enriched_vs_control
• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_Plasma_vs_WY-14,643_Plasma
• Control_vs_AONFH_Stage_III_IV
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Hanks_balanced_salt_solution_vs_doxycycline
• 4_weeks_vs_52_weeks
• Control_vs_Palmitate